Acceptability, User Satisfaction, and Feasibility of an App-Based Support Service During the COVID-19 Pandemic in a Psychiatric Outpatient Setting: Prospective Longitudinal Observational Study.

Publication date: Dec 04, 2024

Patients with mental disorders often have difficulties maintaining a daily routine, which can lead to exacerbated symptoms. It is known that apps can help manage mental health in a low-threshold way and can be used in therapeutic settings to complement existing therapies. The aim of this study was to evaluate the acceptability, usability, and feasibility of an app-based support service specifically developed for outpatients with severe mental disorders in addition to regular face-to-face therapy during the COVID-19 pandemic. Patients in a psychiatric outpatient department at a German university hospital were invited to use an app-based support service designed transdiagnostically for mental disorders for 4 weeks. The app included 7 relaxation modules, consisting of video, audio, and psychoeducational text; ecological momentary assessment-like questionnaires on daily mood answered via a visual smiley-face scale; and an activity button to record and encourage daily activities. Standardized questionnaires at baseline (T0; preintervention time point) and after 4 weeks (T2; postintervention time point) were analyzed. Feedback via the smiley-face scale was provided after using the app components (T1; during the intervention). Measures included depressive symptoms, quality of life, treatment credibility and expectancy, and satisfaction. Furthermore, participation rates, use of app modules and the activity button, and daily mood and the provided feedback were analyzed (T2). In total, 57 patients participated in the study, and the data of 38 (67%) were analyzed; 17 (30%) dropped out. Satisfaction with the app was high, with 53% (30/57) of the participants stating being rather satisfied or satisfied. Furthermore, 79% (30/38) of completers stated they would be more likely or were definitely likely to use an app-based support service again and recommend it. Feasibility and acceptability were high, with nearly half (18/38, 47%) of the completers trying relaxation modules and 71% (27/38) regularly responding to the ecological momentary assessment-like questionnaire between 15 and 28 times (mean 19. 91, SD 7. 57 times). The activity button was used on average 12 (SD 15. 72) times per completer, and 58% (22/38) felt “definitely” or “rather” encouraged to perform the corresponding activities. Depressive symptomatology improved significantly at the postintervention time point (P=. 02). Quality of life showed a nonsignificant increase in the physical, psychological, and social domains (P=. 59, P=. 06, and P=. 42, respectively) and a significant improvement in the environment domain (P=. 004). Treatment credibility and expectancy scores were moderate and significantly decreased at T2 (P=. 02 and P

Open Access PDF

Concepts Keywords
Apps Adult
Daily Aged
German app
Outpatient app-based support
COVID-19
COVID-19
eHealth
Feasibility Studies
Female
Germany
health care
Humans
Longitudinal Studies
Male
Mental Disorders
mental health
Middle Aged
Mobile Applications
mobile phone
Outpatients
Pandemics
Patient Satisfaction
Prospective Studies
psychiatric symptoms
Quality of Life
Surveys and Questionnaires

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH mental disorders
disease IDO intervention
disease MESH depressive symptoms
disease IDO quality
disease MESH anxiety
disease MESH obsessive compulsive disorder
disease MESH comorbidity
disease IDO process
drug DRUGBANK Methyltestosterone
disease MESH emergency
disease MESH marital status
disease MESH psychological distress
disease MESH psychological well being
pathway REACTOME Translation
disease MESH infection
disease MESH personality disorder
disease MESH anxiety disorder
disease MESH schizophrenia
disease MESH depressive disorder
drug DRUGBANK Aspartame
disease MESH attention deficit hyperactivity disorder
disease MESH panic disorder
disease MESH paranoid schizophrenia
disease MESH suicide

Original Article

(Visited 1 times, 1 visits today)